These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 6460313)

  • 1. [Diphosphonates in the treatment of bone metastases].
    Jung A; Fleisch H
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates in the treatment of malignant bone disease.
    Berenson JR; Lipton A
    Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
    Coleman RE
    Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New diphosphonates to block bone resorption.
    Raisz LG
    N Engl J Med; 1980 Feb; 302(6):347-8. PubMed ID: 6444242
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat.
    Jung A; Bornand J; Mermillod B; Edouard C; Meunier PJ
    Cancer Res; 1984 Jul; 44(7):3007-11. PubMed ID: 6233002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aredia: the once-monthly infusion for the treatment of bone metastases.
    Lipton A
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
    Elomaa I; Blomqvist C; Porkka L; Lamberg-Allardt C; Borgström GH
    Bone; 1987; 8 Suppl 1():S53-6. PubMed ID: 2961355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Paget's disease of bone.
    Langston AL; Ralston SH
    Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström GH
    Biomed Pharmacother; 1988; 42(2):111-6. PubMed ID: 2971403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE; Siris ES; Jacobs TP
    Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphosphonates for otospongiosis.
    Stutzmann JJ; Petrovic AG
    Am J Otol; 1985 Jan; 6(1):89-95. PubMed ID: 3156507
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential role of bisphosphonates in prostate cancer.
    Oades GM; Coxon J; Colston KW
    Prostate Cancer Prostatic Dis; 2002; 5(4):264-72. PubMed ID: 12627210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
    Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
    Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multifocal sarcoma associated with Paget's disease of bone. Effects of dichloromethylene diphosphate (author's transl)].
    Vergnon JM; Cheix F; Vauzelle JL; Charhon S; Meunier PJ
    Nouv Presse Med; 1981 Jun; 10(28):2353-4, 2359-60. PubMed ID: 6455648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dichloromethylene diphosphonate in the treatment of lytic bone metastases].
    Chantraine A; Jung A; van Ouwenaller C; Donath A
    Presse Med; 1984 Feb; 13(8):479-82. PubMed ID: 6230629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I; Kousidou OCh; Karamanos NK
    In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin or diphosphonates for osteolytic Paget's disease?
    Nagant de Deuxchaisnes C; Rombouts-Lindemans C; Huaux JP; Devogelaer JP; Malghem J; Maldague B
    Lancet; 1980 Feb; 1(8164):374. PubMed ID: 6101833
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possibilities of diphosphonates in the therapy of bone diseases].
    Bonjour JP; Rizzoli R
    Rev Med Suisse Romande; 1990 Aug; 110(8):691-4. PubMed ID: 1699260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.